{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:40:06Z","timestamp":1756662006454,"version":"3.44.0"},"reference-count":14,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2014,11,21]]},"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Vitamin B<jats:sub>12<\/jats:sub> and folic acid (referred to as vitamin supplementation) improves the toxicity profile of pemetrexed containing regimens. Low baseline vitamin B<jats:sub>12<\/jats:sub> and folate levels are reflected in a raised total homocysteine level (HC). Studies have suggested that pretreatment HC levels predict neutropenia toxicity. We have tested supplementation with vitamin B<jats:sub>12<\/jats:sub> and folate in non-pemetrexed platinum-based regimens to decrease treatment-related toxicity and looked for a correlation between toxicity and change in homocysteine levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patient and method<\/jats:title>\n                  <jats:p>Eighty-three patients with advanced lung cancer and malignant mesothelioma were randomly assigned to receive platinum-based chemotherapy with (arm A) or without (arm B) vitamin B<jats:sub>12<\/jats:sub> and folic acid supplementation. The primary end point was grade 3\/4 neutropenia and death within 30\u2005days of treatment. Secondary end points included quality of life, overall survival (OS) and the relationship between baseline and post supplementation HC levels and toxicity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the intention-to-treat population, no significant difference was seen between the two groups with respect to chemotherapy-induced grade 3\/4 neutropenia and death within 30\u2005days of chemotherapy (36% vs 37%; p=0.966, emesis (2% vs 6%; p=0.9) or OS (12.3\u2005months vs 7\u2005months; p=0.41). There was no significant difference in survival rates by baseline HC level (p=0.9). Decrease in HC with vitamin supplementation was less frequent than expected. High baseline HC levels decreased with vitamin supplementation in only 9\/36 (25%) patients (successful supplementation). Post hoc analysis showed that patients in arm A who were successfully supplemented (9\/36=25%) had less neutropenic toxicity (0% vs 69%; p=0.02) compared to unsupplemented patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The addition of vitamin B<jats:sub>12<\/jats:sub> and folic acid to platinum-containing regimens did not overall improve the toxicity, quality of life or OS. Rates of grade 3\/4 neutropenia at 36\/37% was as predicted. Further studies to increase the rate of successful supplementation and to further test the biomarker potential of post supplementation HC levels in predicting chemotherapy-induced neutropenia in platinum-based chemotherapy are warranted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number:<\/jats:title>\n                  <jats:p>EudracCT 2005-002736-10 <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"8734355\">ISRCTN8734355<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2014-000061","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T23:15:28Z","timestamp":1418339728000},"page":"e000061","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B<sub>12<\/sub> and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity"],"prefix":"10.1136","volume":"1","clinical-trial-number":[{"clinical-trial-number":"isrctn8734355","registry":"10.18810\/isrctn"}],"author":[{"given":"A R","family":"Minchom","sequence":"first","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Saksornchai","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bhosle","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Gunapala","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Puglisi","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S K","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nimako","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Coward","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K C","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bordi","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Popat","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M E R","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Royal Marsden Hospital, Sutton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"key":"2025083110122713000_1.1.e000061.1","first-page":"835","article-title":"NICE guidance for screening for malnutrition: implications for lung cancer services","volume":"10","author":"Chauhan","year":"2006","journal-title":"Thorax"},{"key":"2025083110122713000_1.1.e000061.2","first-page":"CD009256","article-title":"Cisplatin versus carboplatin in combination for advanced non-small cell lung cancer (review)","volume":"8","author":"de Castria","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025083110122713000_1.1.e000061.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60569-9"},{"key":"2025083110122713000_1.1.e000061.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"2025083110122713000_1.1.e000061.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.05.020"},{"key":"2025083110122713000_1.1.e000061.6","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1200\/JCO.2000.18.10.2095","article-title":"Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy","volume":"18","author":"Shepherd","year":"2000","journal-title":"J Clin Oncol"},{"key":"2025083110122713000_1.1.e000061.7","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.V92.7.2471","article-title":"Nutritional folate status influences the efficacy and toxicity of chemotherapy in rats","volume":"92","author":"Branda","year":"1998","journal-title":"Blood"},{"key":"2025083110122713000_1.1.e000061.8","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2002.128648"},{"key":"2025083110122713000_1.1.e000061.9","doi-asserted-by":"publisher","DOI":"10.1021\/tx950143c"},{"key":"2025083110122713000_1.1.e000061.10","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.1.5.223"},{"key":"2025083110122713000_1.1.e000061.11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/138945010790031072","article-title":"Predictive markers for haematological toxicity of pemetrexed","volume":"11","author":"Kao","year":"2010","journal-title":"Curr Drug Targets"},{"key":"2025083110122713000_1.1.e000061.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7135.894"},{"key":"2025083110122713000_1.1.e000061.13","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.021634"},{"key":"2025083110122713000_1.1.e000061.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.9452"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2014-000061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:12:31Z","timestamp":1756660351000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2014-000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,11]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1136\/bmjresp-2014-000061"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2014-000061","relation":{},"ISSN":["2052-4439"],"issn-type":[{"type":"electronic","value":"2052-4439"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}